Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir Treatment for Chronic Hepatitis B Virus: A Reconstructed Individual Patient Data Meta-analysis

IMPORTANCE: Conventional meta-analyses with aggregated study-level data have yielded conflicting results for the comparative effectiveness of tenofovir disoproxil fumarate vs entecavir in reducing hepatocellular carcinoma (HCC) risk among patients with chronic hepatitis B virus. Within-study heterog...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Darren Jun Hao, Ng, Cheng Han, Tay, Phoebe Wen Lin, Syn, Nicholas, Muthiah, Mark D., Lim, Wen Hui, Tang, Ansel Shao Pin, Lim, Kai En, Lim, Grace En Hui, Tamaki, Nobuharu, Kim, Beom Kyung, Teng, Margaret Li Peng, Fung, James, Loomba, Rohit, Nguyen, Mindie H., Huang, Daniel Q.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244612/
https://www.ncbi.nlm.nih.gov/pubmed/35767258
http://dx.doi.org/10.1001/jamanetworkopen.2022.19407

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244612/
https://www.ncbi.nlm.nih.gov/pubmed/35767258
http://dx.doi.org/10.1001/jamanetworkopen.2022.19407

Ejemplares similares